<P>&nbsp;</P> <P>&nbsp;</P> <P align=justify><STRONG><STRONG><A style="COLOR: #e02020" title="" href="https://www.aderly.com/france-pharmaceutique/entreprise-lyon-sanofi-aventis-pharmaceutique,p,130,EN.jsp" target=_blank>Sanofi</A></STRONG> and its partner <A style="COLOR: #e02020" title="" href="http://www.regeneron.com/" target=_blank>Regeneron</A> announced a clinical trial called Odysee Outcomes</STRONG> during the American Heart Association&#8217;s scientific sessions. <STRONG>The trial will include 18,000 patients and is a phase III trial,</STRONG> meaning it is the last step in testing before a possible launch on the market. The trial will study treating hypercholesterolemia with a monoclonal antibody which blocks the action of enzymes that prevent the destruction of &#8220;bad&#8221; cholesterol. Having high cholesterol is considered one of the principal risk factors for cardiovascular diseases, which are the number one cause of mortality in the world. <STRONG>The outcome of this test could provide a relay for current cholesterol treatments:</STRONG> statins.<BR></P> <P align=justify>&nbsp;</P> <H2>SANOFI PASTEUR: A COMPANY THAT DRIVES BIOTECHNOLOGY&nbsp;IN LYON </H2> <P>&nbsp;</P> <P align=justify><STRONG>Sanofi Pasteur, the <A style="COLOR: #e02020" title="" href="http://www.sanofi.fr/l/fr/fr/index.jsp" target=_blank>Sanofi-Aventis </A>group&#8217;s vaccine division, is entirely dedicated to human vaccines</STRONG> and is the world leader, producing 1.6 billion doses every year. <STRONG>Its international headquarters are located in <A style="COLOR: #e02020" title="" href="https://www.aderly.com/centre-recherche-et/developpement-france,p,21,EN.jsp" target=_blank>the Gerland district of Lyon</A>, which is both a technopole and biotechnology research pole. As the epicenter of the <A style="COLOR: #e02020" title="" href="https://www.aderly.com/Infectiologie/index,p,157,EN.jsp" target=_blank>infectious diseases </A>world competitiveness cluster, <A style="COLOR: #e02020" title="" href="https://www.aderly.com/lyon-biopole-pole-centre-recherche-scientifique/index,p,98,EN.jsp" target=_blank>Lyonbiopole</A>,</STRONG> the neighborhood is home to several leading companies specialized in human and animal health, as well as research and university-level teaching centers on the <A style="COLOR: #e02020" title="" href="http://www.universite-lyon.fr/lyon-cite-campus/campus-charles-merieux-134749.kjsp" target=_blank>Charles M&#233;rieux campus</A>. <STRONG>Sanofi Pasteur is an important player in the <A style="COLOR: #e02020" title="" href="https://www.aderly.com/biotechnologie-france-europe/biopole-lyon,p,6,EN.jsp" target=_blank>biotechnology sector </A>in Lyon,</STRONG> with over 4,000 employees and over &#8364;1M invested each day in <A style="COLOR: #e02020" title="" href="https://www.aderly.com/pepiniere-entreprise/centre-recherche,p,16,EN.jsp" target=_blank>R&amp;D</A>.<BR></P>